The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of Gamma Interferon
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of Gamma Interferon
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 86, Issue 8, Pages 4566-4577
Publisher
American Society for Microbiology
Online
2012-02-09
DOI
10.1128/jvi.05545-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolonged Microglial Cell Activation and Lymphocyte Infiltration following Experimental Herpes Encephalitis
- (2014) C. P. Marques et al. JOURNAL OF IMMUNOLOGY
- Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
- (2011) D. Ostertag et al. NEURO-ONCOLOGY
- Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells
- (2010) Thi Lien-Anh Nguyen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model
- (2010) Atique U Ahmed et al. MOLECULAR THERAPY
- Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy
- (2010) Stephen H Thorne et al. MOLECULAR THERAPY
- Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis
- (2009) Cai Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pharmacologic and Chemical Adjuvants in Tumor Virotherapy
- (2009) Christopher Alvarez-Breckenridge et al. CHEMICAL REVIEWS
- Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
- (2009) X. Q. Lun et al. CLINICAL CANCER RESEARCH
- Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cellsin vitro
- (2009) Brigitte Kircher et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Converting Tumor-specific Markers Into Reporters of Oncolytic Virus Infection
- (2009) Ianko D Iankov et al. MOLECULAR THERAPY
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
- (2008) I.-K. Park et al. BLOOD
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus
- (2008) J. Qiao et al. CLINICAL CANCER RESEARCH
- Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
- (2008) Kazuhiko Kurozumi et al. MOLECULAR THERAPY
- Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
- (2008) Akihiro Otsuki et al. MOLECULAR THERAPY
- Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas
- (2008) Peter Forsyth et al. MOLECULAR THERAPY
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
- Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16
- (2008) M Aghi et al. ONCOGENE
- Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
- (2008) T. L.-A. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
- (2007) Jennifer Altomonte et al. MOLECULAR THERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started